{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:40:10Z","timestamp":1759023610787,"version":"3.44.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroscience Methods"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jneumeth.2024.110082","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T03:38:56Z","timestamp":1708486736000},"page":"110082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of a vestibular schwannoma tumor slice model for pharmacological testing"],"prefix":"10.1016","volume":"405","author":[{"given":"Vera","family":"Nickl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Fakler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ziebolz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Rumpel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linus","family":"Stabenow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Bernhagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Rampeltshammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf-Ingo","family":"Ernestus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"L\u00f6hr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Gugel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cordula","family":"Matthies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camelia M.","family":"Monoranu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Hagemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Breun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jneumeth.2024.110082_bib1","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/MAO.0b013e31821f7d88","article-title":"ErbB expression, activation, and inhibition with lapatinib and tyrphostin (AG825) in human vestibular schwannomas","volume":"32","author":"Ahmad","year":"2011","journal-title":"Otol. Neurotol."},{"issue":"8","key":"10.1016\/j.jneumeth.2024.110082_bib2","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/neuonc\/noq012","article-title":"ErbB\/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma","volume":"12","author":"Ammoun","year":"2010","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.jneumeth.2024.110082_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2020.108633","article-title":"3D in vitro test system for vestibular schwannoma","volume":"336","author":"Breun","year":"2020","journal-title":"J. Neurosci. Methods"},{"issue":"2","key":"10.1016\/j.jneumeth.2024.110082_bib4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41596-018-0105-7","article-title":"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma","volume":"14","author":"Chen","year":"2019","journal-title":"Nat. Protoc."},{"issue":"3","key":"10.1016\/j.jneumeth.2024.110082_bib5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/2472630317697251","article-title":"3D Culture as a Clinically Relevant Model for Personalized Medicine","volume":"22","author":"Fong","year":"2017","journal-title":"SLAS Technol."},{"issue":"1","key":"10.1016\/j.jneumeth.2024.110082_bib6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12916-020-01610-0","article-title":"Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma","volume":"18","author":"Garc\u00eda-Romero","year":"2020","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.jneumeth.2024.110082_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nprot.2006.486","article-title":"Human and rat adult Schwann cell cultures: fast and efficient enrichment and highly effective non-viral transfection protocol","volume":"2","author":"Haastert","year":"2007","journal-title":"Nat. Protoc."},{"issue":"Pt 3","key":"10.1016\/j.jneumeth.2024.110082_bib8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/brain\/awm249","article-title":"Magic but treatable? Tumours due to loss of merlin","volume":"131","author":"Hanemann","year":"2008","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.jneumeth.2024.110082_bib9","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/neuonc\/nos146","article-title":"Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas","volume":"14","author":"Karajannis","year":"2012","journal-title":"Neuro Oncol."},{"issue":"7","key":"10.1016\/j.jneumeth.2024.110082_bib10","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ctrv.2014.05.004","article-title":"Systemic therapy in neurofibromatosis type 2","volume":"40","author":"Lim","year":"2014","journal-title":"Cancer Treat. Rev."},{"issue":"8","key":"10.1016\/j.jneumeth.2024.110082_bib11","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol."},{"issue":"78","key":"10.1016\/j.jneumeth.2024.110082_bib12","doi-asserted-by":"crossref","DOI":"10.3791\/50460-v","article-title":"Tissue engineering of a human 3D in vitro tumor test system","author":"Moll","year":"2013","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.jneumeth.2024.110082_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11060-017-2567-9","article-title":"The efficacy of lapatinib and nilotinib in combination with radiation therapy in a model of NF2 associated peripheral schwannoma","volume":"135","author":"Paldor","year":"2017","journal-title":"J. Neurooncol"},{"issue":"6","key":"10.1016\/j.jneumeth.2024.110082_bib14","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/MAO.0b013e31825e73f5","article-title":"Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients","volume":"33","author":"Plotkin","year":"2012","journal-title":"Otol. Neurotol."},{"issue":"7","key":"10.1016\/j.jneumeth.2024.110082_bib15","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/MAO.0b013e3181eb328a","article-title":"Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patients","volume":"31","author":"Plotkin","year":"2010","journal-title":"Otol. Neurotol."},{"issue":"4","key":"10.1016\/j.jneumeth.2024.110082_bib16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1006\/nbdi.2000.0307","article-title":"Enhanced proliferation and potassium conductance of Schwann cells isolated from NF2 schwannomas can be reduced by quinidine","volume":"7","author":"Rosenbaum","year":"2000","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.jneumeth.2024.110082_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039412","article-title":"Investigation of the in vitro therapeutic efficacy of nilotinib in immortalized human NF2-null vestibular schwannoma cells","volume":"7","author":"Sabha","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jneumeth.2024.110082_bib18","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"issue":"7","key":"10.1016\/j.jneumeth.2024.110082_bib19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"issue":"89","key":"10.1016\/j.jneumeth.2024.110082_bib20","doi-asserted-by":"crossref","DOI":"10.3791\/51093-v","article-title":"Primary culture of human vestibular schwannomas","author":"Schularick","year":"2014","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.jneumeth.2024.110082_bib21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3892\/or.2016.5231","article-title":"Expression of angiogenic growth factors VEGF, bFGF and ANG1 in colon cancer after bevacizumab treatment in vitro: A potential self-regulating mechanism","volume":"37","author":"Zhao","year":"2017","journal-title":"Oncol. Rep."}],"container-title":["Journal of Neuroscience Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016502702400027X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016502702400027X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:06:30Z","timestamp":1759021590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016502702400027X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":21,"alternative-id":["S016502702400027X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneumeth.2024.110082","relation":{},"ISSN":["0165-0270"],"issn-type":[{"type":"print","value":"0165-0270"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a vestibular schwannoma tumor slice model for pharmacological testing","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroscience Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneumeth.2024.110082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110082"}}